Author

Guangnan Yao

Institutions: Fujian Medical University, First Affiliated Hospital of Fujian Medical University

Observed institutions: Fujian Medical University, First Affiliated Hospital of Fujian Medical University

ORCID: 0000-0001-9052-1966

Observed ORCID: 0000-0001-9052-1966

OpenAlex ID: A5114098496

Identification and experimental validation of ferroptosis-related gene lactotransferrin in age-related hearing loss

2024 · Chaojun Zeng, Xi Gu, et al. · Frontiers in Aging Neuroscience · 16

The association between high jugular bulb and mastoid pneumatization in adults

2024 · Chenyu Chen, Simin Weng, et al. · Frontiers in Neurology · 4

A retrospective efficacy and safety study of pembrolizumab/cetuximab neoadjuvant therapy in locally advanced hypopharyngeal cancer

2025 · Guangnan Yao, Xiaobo Wu, et al. · Frontiers in Immunology

Second primary malignancy for early‐stage head and neck squamous cell carcinoma by SEER 17 registries

2024 · Hanqing Lin, Xiaobo Wu, et al. · Oral Diseases

Author response for "Second primary malignancy for early‐stage head and neck squamous cell carcinoma by SEER 17 registries"

2024 · Hanqing Lin, Xiaobo Wu, et al.

Identification and validation of N6-methyladenosine (m6A)-related lncRNAs signature for predicting the prognosis of laryngeal carcinoma, especially for smoking patients

2023 · Yuqing Chen, Chenyu Chen, et al. · Frontiers in Genetics

Risk of Second Primary Malignancy after Surgery or Definitive Radiotherapy for Early-Stage Head and Neck Squamous Cell Carcinoma: A Population-based Study

2023 · Hanqing Lin, Xiaobo Wu, et al. · Research Square

Works count: 7

Citation count: 20

H-index: 2

I10-index: 1